JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2003; 42:1161-1170, doi:10.1016/S0735-1097(03)00951-3
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henderson, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henderson, R. A.

Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy

Robert A. Henderson, FRCP, FESC*,*, Stuart J. Pocock, PhD{dagger}, Tim C. Clayton, MSc{dagger}, Rosemary Knight, RGN{dagger}, Keith A. A. Fox, FRCP, FESC{ddagger}, Desmond G. Julian, FRCP, FESC§, Douglas A. Chamberlain, FRCP, FESC|| Second Randomized Intervention Treatment of Angina (RITA-2) Trial Participants

* Nottingham City Hospital, Nottingham, United Kingdom
{dagger} London School of Hygiene and Tropical Medicine, London, United Kingdom
{ddagger} Royal Infirmary, Edinburgh, United Kingdom
§ London, United Kingdom
|| Pre-hospital Emergency Research Unit and Wales Heart Institute, University of Wales College of Medicine, Cardiff, United Kingdom



View larger version (19K):

[in a new window]
  		Figure 1 Cumulative risk of (A) death and (B) death or definite non-fatal myocardial infarction (MI). Bars show 95% confidence interval. Numbers show patients at risk of death or non-fatal MI. PTCA = percutaneous transluminal coronary angioplasty.

 


View larger version (17K):

[in a new window]
  		Figure 2 Non-randomized intervention rates by year of follow-up. CABG = coronary artery bypass graft; PTCA = percutaneous transluminal coronary angioplasty.

 


View larger version (31K):

[in a new window]
  		Figure 3 Prevalence of angina over time at baseline (base), three, and six months, and yearly intervals after randomization. P = coronary angioplasty group; M = medical group.

 



View larger version (61K):

[in a new window]
  		Figure 4 Mean angina grades before and after non-randomized intervention. Panels A and B show data for the percutaneous transluminal coronary angioplasty (PTCA) group. Panels C and D show data for the medical group. Lines are smoothed averages and 95% confidence intervals. The circles show individual data points. Continued on next page. For the medical group (C and D), the triangle indicates angina grade immediately before non-randomized intervention. CABG = coronary artery bypass graft.

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2003 by the American College of Cardiology Foundation.